Paper Poster Presentation Tour in Clinical Hepatology; 8th September, 09:00-17:00, Poster Hall

P3 RELATIONSHIP BETWEEN SERUMAL LEVELS OF ALT, AST, FBS, ANTI FASCIOLA HEPATICA IGG AND NON-ALCOHOLIC FATTY LIVER DISEASE, by Mohammad Taghi Ahady

P14 THE EFFECT OF AEROBIC EXERCISE ON TNF-ALPHA AND ADIPONECTIN IN MILITARY MEN WITH NONALCOHOLIC FATTY LIVER, by Alireza Shamsoddini

P23 HCV IN CHILDREN, by Enayatollah Nematkhorasani

P24 OPIUM CONSUMPTION AND RISK OF LIVER FIBROSIS IN CHRONIC HEPATITIS B AND C, by Seyed Ehsan Asadi

P26 PAIN OR SUFFER IN HEPATITIS: A BIOPSYCHOSOCIAL MODEL OF PAIN SEVERITY, by Manijeh Firoozi

P46 VITAMIN D LEVELS IN DIFFERENT STAGES OF CHRONIC HEPATITIS B, by Shahnaz Sali

P51 HOW TO HEAL PATIENTS WITH B HEPATITIS THROUGH HOMEOPATHY, by Seyedaghanoor Sadeghi

P55 THE RELATIONSHIP BETWEEN REPRODUCTION TECHNIQUES AND LIVER DYSFUNCTION, CASE SERIES AND LITERATURE REVIEW, by Neda Nozari

P71 HEPATITIS B PREGNANT WOMEN AND HEALTH NEEDS, by Elham Ebrahimi

P88 COMPARING THE EFFECTS OF PENDER’S HEALTH BELIEF MODEL AND NURSING CARE AT HOME ON THE HEALTH OF PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE: A RANDOMIZED CLINICAL TRIAL, by Milad Borji

P98 SPECIFIC IMMUNOTHERAPY IN HEPATOCELLULAR CANCER: A SYSTEMATIC REVIEW, by Nastaran Khalili

P101 IMPACT OF HIV INFECTION IN PATIENTS INFECTED WITH CHRONIC HCV, by Rasoul Baharlou

P110 HBV/HCV COINFECTION: A CHALLENGE IN TREATMENT OF CHRONIC HEPATITIS C WITH DIRECTLY ACTING ANTIVIRALS, by Maryam Bahadori

P115 EFFECT OF PROBIOTICS AND PREBIOTIC ON ANTROPOMETRIC INDEX AND SERUM LIPID PROFILE IN ACUTE NON ALCOHOLIC FATTY LIVER FATTY LIVER DISEASES: A DOUBLE BLIND RANDOMIZED CLINICAL TRIAL, by Leila javadi

P116 THE SUSTAINED VIROLOGIC RESPONSE AND COMPLICATIONS OF PEG INTERFERON ALFA AND RIBAVIRIN IN IRANIAN PATIENTS WITH CHRONIC HEPATITIS C   , by Azadeh Laali

P118 THE EXPERIENCES OF THE HEPATITIS B CARRIERS IN ADAPTATION WITH THE DISEASE: A QUALITATIVE STUDY, by Ali Zabihi

P119 A COMPARISON BETWEEN THE STANDARD PEGYLATED INTERFERON AND RIBAVIRIN REGIMEN WITH AND WITHOUT VITAMIN B12 SUPPLEMENTATION ON SUSTAINED VIROLOGIC RESPONSE RATE IN CHRONIC HCV HEPATITIS IN IRAN, A RANDOMIZED CLINICAL TRIAL    , by Marjan Mokhtare

P120 FREQUENCY AND RISK FACTORS FOR DRUG-INDUCED HEPATITIS IN TUBERCULOSIS AT TWO HOSPITALS IN TEHRAN DURING 2009-2015, by Saeed Soleiman Meigooni

P133 EVALUATION OF HEMOGLOBIN OVERSATURATION IN CIRRHOTIC PATIENTS, by Ali Adib

P135 COGNITIVE FUNCTION IN IRANIAN PATIENTS WITH HEPATITIS C, by Zahra Amirsardari

P137 COMPARISON STUDY OF CAROTID INTIMA MEDIA THICKNESS IN NONALCOHOLIC FATTY LIVER AND CONTROL GROUP, by Tahereh Fakharian

P150 CHRONIC HEPATITIS B INFECTION AND PREGNANCY, by Farzaneh Gholamalian

P151 THE ASSOCIATION BETWEEN HEPATITIS INFECTION AND ORAL LICHEN PLANUS: REVIEW STUDY      , by Maryam Koopaie

P158 ORAL MANIFESTATION OF HCV INFECTION (A REVIEW STUDY), by Maryam Koopaie

P164 TREATMENT RESPONSE RATES IN PAKISTANI HEPATITIS C VIRUS PATIENTS; CURRENT PROSPECTS AND FUTURE CHALLENGES, by Muhammad Ali

P187 DETERMINING THE ASSOCIATION OF PROGNOSTIC FACTORS ON SURVIVAL OF LIVER CIRRHOSIS PATIENTS: A FRAILTY MODEL APPROACH, by Elnaz Saeedi

P188 ETIOLOGY OF HEPATIC CYSTIC HYDATIDOSIS IN BIRJAND, EASTERN IRAN, by Mehdi Karamian

P195 OUTCOME OF INACTIVE CARRIERS OF HBV IN 10 YEARS FOLLOW-UP IN IRAN, by Zahrasadat Seghatoleslami

P203 REGULATION OF HEPATIC FUNCTION BY CENTRAL FATTY ACIDS, by Sepideh Ghodousifar